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ABSTRACT 
Articular cartilage is essential part of the human body that aids in support and 
locomotion.  It has unique biochemical and biomechanical properties that allow it to act 
as a shock absorber to disperse and distribute loading of the joints.  However, it has a 
limited capacity to repair itself because it is not vascularized and must receive its 
nutrients from the surrounding synovial fluid.  Articular cartilage damage can lead to 
many pathological conditions, including osteoarthritis.  Currently, there are many 
surgical treatment methods that repair some of the damage if it is localized, but for 
widespread degradation seen in osteoarthritis, there are no effective means of reparative 
treatments.  Research has been ongoing to find a cure for this degeneration, and recently 
there has been focus on the potential of using nanoparticles as a drug delivery method in 
treating articular cartilage damage.  Nanoparticles could be used to deliver growth 
factors, drugs, or genes to attempt to restore the tissue to its native state.  However, the 
permeation of nanoparticles due to physiological loading of articular cartilage must first 
be characterized. 
 To conduct experiments on articular cartilage, a means of providing physiological 
compressive loading had to be established.  After consulting the literature, a custom-
designed dynamic compression loading apparatus was constructed.  It was controlled 
using an electro-mechanical linear actuator, specifically an eccentric cam, to provide 
various loading conditions of frequency and strain.  It was determined that the device 
could consistently and accurately provide axial loading in the physiological range for 
articular cartilage applications. 
iii 
To characterize the permeation of nanoparticles in articular cartilage, experiments 
were carried out with cartilage exposed to gold nanoparticles under various loading 
conditions using the custom designed compression device. The tissue was then observed 
with electron microscopy to observe the presence of gold nanoparticles.  The images 
taken qualitatively indicated the extent of gold nanoparticle permeation on the surface 
and inside the cartilage.  It was seen that the gold nanoparticles were only observed in the 
dynamically compressed tissue in varying amounts.  The cartilage tissue under higher 
frequency axial loading in the physiological range showed a greater amount of 
nanoparticle permeation. However, more work needs to be done to understand the zones 
of the articular cartilage that are affected by the convective transport and permeation of 
the gold nanoparticles. 
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CHAPTER 1: GOLD NANOPARTICLE DRUG DELIVERY  
FOR ARTICULAR CARTILAGE REPAIR 
1.1 Market Analysis of Articular Cartilage Damage in the US 
There is a large market for articular cartilage repair, specifically with regard to 
osteoarthritic damage.  Osteoarthritis is one of the most common form of chronic 
disability, and in the US, it accounts for 3.4-13.2 billion USD per year in work-related 
limitations costs
1
.  Healthcare treatments in 2004 amounted to over 11 million 
physician/outpatient visits, 632,000 joint replacements, and 662,000 hospitalizations, 
bringing the total healthcare cost to 22.6 billion USD
2
.  Unfortunately with an aging 
population and increased prevalence of obesity, the disease is increasing in the number of 
cases and, subsequently, the total cost.  
1.2 Current Treatments to Repair Articular Cartilage 
 Due to the avascular nature of articular cartilage, there is an extremely limited 
capacity for self-renewal, and thus, the patient must decide whether to live with the 
cartilage damage and associated complications or seek out clinical intervention.  
Currently, there are several surgical methods that repair localized articular cartilage 
damage and slow further deterioration.  However, when there is widespread damage as 
seen in osteoarthritis, there are no effective means of repairing the tissue, and often times 
a joint replacement surgery is recommended.   
2 
1.3 Gold Nanoparticles for Drug Delivery  
In the case of avascular articular cartilage, traditional treatment methods of 
administering drugs through the circulatory system cannot be used and the treatment must 
be done locally.  Gold nanoparticles have optimal properties that make it an ideal smart 
drug delivery system for the administration of drugs, growth factors, or genes for 
cartilage repair.  
1.4 Overview of Study and Chapters  
The following studies aim to determine the effects of physiological loading of 
articular cartilage on the permeation of gold nanoparticles.  The purpose is to determine 
the effectiveness of these nanoparticles as a means of drug delivery through convective 
transport.  Chapter 2 provides an overview of cartilage anatomy and physiology, 
specifically with regard to articular cartilage.  In Chapter 3, an introduction to gold 
nanoparticles is given as well as a look into their potential use in drug delivery to repair 
articular cartilage damage.  The design and construction of a custom dynamic 
compression loading apparatus is described in Chapter 4.  In Chapter 5, the experiments 
that were conducted to determine gold nanoparticle permeation are detailed as well as the 
subsequent results that were obtained.  Finally, Chapter 6 summarizes the findings of the 
studies as well as the potential for future work. 
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CHAPTER 2: ARTICULAR CARTILAGE ANATOMY AND PHYSIOLOGY 
 
 In order to determine if gold nanoparticles as a drug delivery system would be an 
effective means of treating cartilage damage, it is necessary to understand the articular 
cartilage anatomy and physiology.  The following chapter gives an overview of cartilage 
anatomy and physiology as well as common pathologies affecting the normal function of 
this tissue.  The chapter also discusses the need for more effective solution to repair 
damaged cartilage that is not as invasive as the current range of treatment options. 
 
2.1 Cartilage Anatomy and Physiology 
 The musculoskeletal system functions to support the structure of the body and 
give humans the ability of locomotion.  It consists of bones, which make up a skeleton of 
hard tissue, and soft tissues such as the muscles, ligaments, tendons, and cartilage, which 
connect the skeleton together at joints. Cartilage is an essential component of the human 
anatomy, and it serves many physiological roles in the musculoskeletal system.  The 
primary functions are to support surrounding soft tissue, to provide an articulating surface 
between bones, and to serve as a framework for bone formation.  Structurally, cartilage is 
a supporting connective tissue that is both flexible and resilient.  The extracellular matrix 
makes up more than 95% of the cartilage volume
3
 and is composed of collagen and 
elastin fibers embedded in an extensive ground substance that is rich in protein-
polysaccharide complexes known as proteoglycans.  The cells that make up the other less 
than 5% of cartilage tissue are called chondrocytes, and they occupy compartments in the 
5 
extracellular matrix called lacunae.  These cells serve to produce and maintain the ground 
substance.  There are three types of anatomically and physiologically different cartilage: 
hyaline cartilage, elastic cartilage, and fibrocartilage.   
 
 
 
 
 
 
 
 
 
 
 
 
They are characterized by the composition of the extracellular matrix found and 
the function in the body, as seen in Figure 2.1.  Hyaline cartilage contains fine collagen 
fibers, elastic cartilage contains densely-packed elastic fibers, and fibrocartilage contains 
large collagen fibers
4
.  For the purposes of this study, we will focus solely on hyaline 
cartilage found in the joints. 
  
Figure 2.1: Cartilage Distribution in the Body
11
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 Hyaline cartilage is the most common type of cartilage and its name comes from 
the Greek word hyalos meaning glassy due to its glassy, white appearance.  It can be 
found on the ends of long bones in articulating joints, in which case it can also be referred 
to as articular cartilage.  Articular cartilage has a low friction coefficient, thus providing a 
surface that allows for smooth movement.  The components in its biochemical structure, 
discussed below, give it the ability to effectively disperse and distribute the loading 
experienced in the joint, acting as a shock absorber.  The thickness of the articular 
cartilage varies from joint to joint
5
, but is approximately 2-4 mm in the human hip and 
knee
6
.  The classification of hyaline cartilage is determined by its function in the body 
and the molecular composition of its extracellular matrix.  The relative molecular 
composition of the cartilage itself and the extracellular matrix is shown in Figure 2.2. 
The collagen fibers that are present in the extracellular matrix serve as a meshwork to 
resist tensile forces experienced upon the joint.  Collagen is a protein that is produced by 
chondrocytes, and in adult articular cartilage type II is the most predominant at around 
Figure 2.2: Biochemical Composition of Hyaline Cartilage
3
 
7 
80% of total collagen content
3
, although types III, VI, IX, X, XI, XII, and XIV are also 
present.  Collagen is structured as a triple helix of chains that are composed of a repeating 
amino acid sequence of glycines, prolines, and hydroxyprolines.  It is found throughout 
articular cartilage as collagenous fibrils arranged in various orientations to resist tensile 
forces in the joint. 
The proteoglycans that make up the next highest percentage of the extracellular 
matrix function to resist compressive forces experienced upon the joint.  They are 
comprised of a protein core to which polysaccharide chains are attached.  These chains 
are also known as glycosaminoglycans or GAGs, and hyaline cartilage contains three 
kinds: hyaluronan, chondroitin sulfate, and keratin sulfate.  Aggregran molecules are the 
most prevalent proteoglycan in adult articular cartilage.  These molecules consist of 
chondroitin sulfate and keratin sulfate attached to a protein core.  Additionally, the 
aggrecan structures will bind to a single chain of hyaluronan via the presence and 
stabilization of a link protein to form a proteoglycan aggregate
7
, as seen below in Figure 
2.3. 
 
 
 
 
 
Figure 2.3: Structure of a Proteoglycan Aggregate 
Image from Wikimedia Commons
54 
8 
These large macromolecules are immobilized within the collagen network of the cartilage 
ground substance, and it is here that they absorb water.  This swelling that occurs is due 
to the net negative charge or hydrophilicity of the sulfate groups on the GAG chains to 
create a “fixed charge density”8.  This accounts for the 60-80% water content found in 
articular cartilage
3
, and it is the reason that cartilage is so effective at dispersing and 
distributing compressive loads in the joint.  The compression of cartilage leads to 
pressurization of the fluid, which supports the majority of the initial compressive load 
and acts to make the cartilage last longer with age.  However, the decrease in 
proteoglycan size due to aging
9,10
 can cause a decreased fluid pressurization, causing the 
cartilage itself to experience higher mechanical loading.  Over time this improper loading 
can lead to deterioration of the articular cartilage and is seen in diseases, such as 
osteoarthritis, which will be discussed in subsequent sections. 
 The articular cartilage is divided into four basic zones, seen below in Figure 2.4, 
and they are organized based on their location and morphology.   
 
 
 
 
 
 
IZ 
D
S
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Figure 2.4: Classification of Zones in Normal Articular Cartilage  
SZ: Superficial Zone, IZ: Intermediate Zone, DZ: Deep Zone, 
CZ: Calcified Zone (H&E, 40x Total Magnification) 
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The first zone is known as the superficial or tangential zone, which makes up about 10-
20% of the cartilage thickness.  It is located on the surface of the articular cartilage and 
composed of fine, densely-packed collagenous fibers and flattened chondrocytes arranged 
tangentially to the loaded surface.  The second zone is the intermediate zone, which is 
also known as the middle zone or transitional zone, and it accounts for 40-60% of the 
cartilage thickness.  This layer consists of randomly oriented collagen fibers of large 
diameter and spherically shaped chondrocytes.  The deep zone makes up 20-50% of the 
cartilage thickness, and it is the last layer with solely hyaline cartilage with no bone 
tissue.  The collagen fibers are arranged perpendicular to the weight bearing surface, and 
the chondrocytes are grouped together in columns.  The final layer is known as the 
calcified zone, which is where the region of cartilage tissue is becoming ossified and is 
transitioning to bone tissue.  Underneath this layer is the subchondral bone, which 
attaches to the cartilage to serve as an anchorage point.  The individual layers can be 
more closely examined in Figure 2.5 below. 
 
 
 
 
 
 
 
SZ 
IZ DZ 
Figure 2.5: Zones of Normal Articular Cartilage  
SZ: Superficial Zone, IZ: Intermediate Zone, DZ: Deep 
Zone (H&E, 40x Total Magnification) 
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2.2 Articular Cartilage Damage and Repair Mechanisms 
 As noted in the previous section, articular cartilage is a resilient tissue that is able 
to withstand the constant stresses placed on the joints throughout a human lifespan.  
However, when there is damage to the cartilage, there is an extremely limited healing 
response.  The reason for the limited repair capabilities of cartilage lies in its unique 
anatomical and physiological properties.  In order to maintain its biomechanical 
properties, the chondrocytes in articular cartilage produce a chemical that prevents the 
vasculature from occupying any part of the extracellular matrix
11
.  This means that the 
tissue is avascular, and the cells contained in the tissue must exchange nutrients or waste 
with the synovial fluid.  The exchange of these substances occurs by diffusion across the 
cartilage surface and is mediated by physiological motion in the joint.  For this purpose, 
the articular cartilage exhibits permeability properties that favor small molecule 
diffusion.  It has been shown that small molecules have diffusion coefficients in cartilage 
of approximately 40% in aqueous solutions, whereas larger molecules are much more 
restricted
12
.  Other reasons for the lack of a healing response to injury include the slow 
movement of lacunae-bound chondrocytes and the limited proliferation capabilities of 
mature chondrocytes.   
In order to analyze articular cartilage damage, a classification system was 
developed to have a uniform system of measuring the extent of the damage, as shown in 
Table 2.1.  Partial-thickness defects, seen in grade II and III injuries, are those in which 
the damage does not penetrate into the subchondral bone.  They can be characterized by 
decreased proteoglycan content and increased hydration, which correlates to decreased 
11 
cartilage stiffness, increased hydraulic permeability, and eventually increased 
extracellular matrix damage
13
.  These partial-thickness injuries exhibit little to no 
spontaneous healing and can lead to further deterioration of the articular cartilage.  Full-
thickness defects, seen in grade IV injuries, are those in which the damage penetrates into 
the subchondral bone.  These injuries exhibit an alternative repair mechanism as blood 
from the underlying vasculature promotes scar tissue formation.  However, the scar tissue 
that forms is composed of fibrocartilage, which is denser than and not as flexible as 
hyaline cartilage
13
.  It is this inability to effectively heal damaged regions of the cartilage 
that lead to the various pathologies discussed in the next section. 
Table 2.1: Classification of Structural Damage to Articular Cartilage
14
 
Grade 0 Normal cartilage 
Grade I Softening and swelling of cartilage 
Grade II Presence of a partial-thickness defect that 
consists of fragmentation and fissures that 
do not reach the underlying bone or are less 
than 1.5 cm in diameter 
Grade III Presence of a partial-thickness defect that 
consists of fragmentation and fissures that 
reach the underlying bone in an area 
greater than 1.5 cm in diameter  
Grade IV Presence of a full-thickness defect that 
exposes subchondral bone 
 
2.3 Pathologies 
 There are several pathologies that can result in articular cartilage degradation, but 
the primary mechanisms of damage are traumatic injury and osteoarthritis.  Traumatic 
12 
injuries are those in which the articular cartilage in a joint experiences a high energy 
impact or repeated loading of non-ideal conditions over a long period of time.  Injurious 
impact loading has been defined as a very small time to peak load and also having one of 
the following characteristics: a stress rate of greater than 1000 
   
 
, a strain rate of greater 
than 500 
 
 
, or a loading rate greater than 100 
  
 
15
.  However, cartilage injury can still 
occur if repeated compression of smaller, yet still non-ideal, loads and frequencies take 
place over a long period of time.  This compressive loading over time is the basis of the 
other primary mechanism of cartilage damage, known as osteoarthritis. 
 Osteoarthritis, also known as degenerative joint disease, is a form of articular 
cartilage damage referred to as the normal “wear and tear” on a joint.  The underlying 
cause is unknown, but osteoarthritis is known to be associated with loading of the joint 
over time that is due to aging.  It can affect any joint in the body, but it is primarily found 
in the load bearing joints of the hips and knees as well as the joints of the hands, feet, and 
spine.  The symptoms of the disease are pain, stiffness, swelling, and even loss of motion 
in a joint.  It is the most common joint disorder— more than half of the US adult 
population develops osteoarthritis
16
.  With an aging population, increased life 
expectancy, and the increase in obesity, osteoarthritis is expected to become more 
prevalent than the 27 million adult Americans already living with the disease in 2005
17
.  
At present, there are no cures for osteoarthritis, and the disease gradually gets worse over 
time.  The staggering statistics and current lack of a cure bring light to a grave situation 
for which a better solution should be researched exhaustively.    
13 
2.4 Current Treatments 
 There are no extremely effective ways to diagnose cartilage injury noninvasively, 
but MRI have proven to be a valuable tool in providing anatomic details of the extent of 
cartilage injury through noninvasive means
18.  The current “gold-standard” in detecting 
cartilage damage is through minimally invasive means of arthroscopy, in which the 
surgeon will make a small incision to insert an endoscope for observation.  Once the 
damage has been assessed, the consulting physician and patient can pursue a course of 
action.  Currently there is no cure for cartilage damage, but there are a number of ways 
that the effects of articular cartilage damage can treated through non-surgical and surgical 
methods.  In order to manage the damage non-operatively, the patient can take non-
steroidal anti-inflammatory drugs (NSAIDS) to reduce pain, exercise daily to improve 
joint movement, lose weight to reduce loading on the joint, or seek physical therapy to 
rehabilitate the injury.  There are several surgical techniques that have been developed by 
surgeons and researchers to attempt to slow the progression of deterioration by repairing 
damage and joint function.  They can be grouped into four main categories: arthroscopic 
lavage/debridement, marrow-stimulation, osteochondral grafts, and cell-based repair. 
 The first surgical technique is known as the arthroscopic repair procedure of 
lavage and debridement, and it is a simple method that is moderately useful for short-
term treatment.  Lavage is the washing out of the joint to clear away any debris, and 
though its mechanism is unclear, it has been shown to relieve joint pain
19
.  Debridement 
is the removal of any damaged tissue, especially loose flaps that may be causing 
impingement of the joint.  The category of arthroscopic repair is a bit of misnomer, as the 
14 
techniques used only clean up the affected area and do not repair the tissue.  Thus, this 
method is not usually recommended due to the beneficial results diminishing after only a 
few short years. 
 Another procedure that is performed with arthroscopy is the marrow-stimulating 
technique of microfracture surgery.  It involves the creation of small holes or 
microfractures that penetrate into the subchondral bone to allow the blood supply to 
repair the tissue.  The blood contains primitive stem cells and forms a fibrin clot, which 
then remodels to fibrocartilage.  As discussed above, the fibrocartilage does not possess 
the same mechanical properties of hyaline cartilage, and thus the articular cartilage is not 
fully repair and may experience further degradation.  This method is generally performed 
on patients younger than 40, typically athletes or those having traumatic impact injuries, 
with localized small amounts of cartilage damage.   
 Osteochondral autografts and allografts may be also be used to attempt to repair 
the articular cartilage damage in a joint.  This procedure is typically known as 
osteoarticular transfer system (OATS) or mosaicplasty.  It involves the moving of 
cartilage from undamaged, non-load bearing parts of the joint to the affected area.  Small 
plugs of tissue are excised and then implanted into holes that have been drilled out of the 
damaged region.  Unfortunately, the region that the cartilage was taken from can suffer 
donor site morbidity.  This method is generally performed on patients younger than 50, 
typically athletes or those having traumatic impact injuries, with localized small amounts 
of cartilage damage. 
15 
 The procedure of autologous chondrocyte implantation (ACI) is a cell-based 
repair treatment that is more advanced than the other procedures and has becoming more 
widespread.  It involves the harvesting of the patient’s own chondrocytes, which are then 
cultured over four to six weeks and then reimplanted into the damaged region of the 
cartilage to repair the defect.  In this manner, hyaline cartilage is the tissue that fills in the 
affected area, not fibrocartilage.  One of the problems with this procedure is the 
unintended necessity of follow-up arthroscopic surgeries.  This method is generally 
performed on patients younger than 60, typically athletes or those having traumatic 
impact injuries, with localized small amounts of cartilage damage. 
 These treatment methods are primarily used to repair small areas of cartilage 
damage, but in the case of widespread articular cartilage damage seen in severe 
osteoarthritis, treatment options are extremely limited.  If none of the above non-surgical 
or surgical treatments are appropriate or effective in treating severe osteoarthritis, then 
joint replacement surgery may be the best option.  Joint replacement surgery or 
arthroplasty, involves the removal of the damaged articular surface and replacing it with 
prosthesis.  It is the most common form of relieving joint pain and restoring motion in the 
treatment of severe osteoarthritis.  However, these methods of treatment show moderate 
results at best, and thus there is a pressing need for a more effective means of treatment in 
articular cartilage damage.  The potential for using gold nanoparticles as an alternative 
means of cartilage repair is currently under investigation and will be discussed in the next 
chapter. 
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CHAPTER 3: CLINICAL SIGNIFICANCE OF GOLD NANOPARTICLES  
 
 In order to understand the possible use of gold nanoparticles as a drug delivery 
system for the treatment of articular cartilage damage, it is necessary to characterize their 
properties.  The following chapter gives an overview of gold nanoparticles as well as 
common biological applications in fields of imaging and targeted drug delivery.  The 
application of gold nanotechnology in the field of cartilage tissue engineering and repair 
will also be discussed. 
 
3.1 Introduction to Gold Nanoparticles 
 Gold nanoparticles, or AuNPs, have been known since ancient times, but it is not 
until relatively recently that they have undergone more rigorous investigation.  As far as 
biomedical applications, colloidal gold has only been in use since 1971
20
.  They are sub-
micrometer sized particles that are suspended in a fluid and exhibit unique optical, 
electronic, and magnetic properties that can be altered during their synthesis, based on the 
manufactured size and shape of the particles
21
.  Gold nanoparticles are also 
biocompatible, ideal dimensions, and are easily characterized.  Their biocompatibility in 
the body, paradoxically in addition to their high chemical reactivity, is of great interest 
for biomedical applications
22
.  The nanoparticles have a solid core that gives them 
stability and a monolayer that is able to undergo thiol surface modification for specific 
biological application.  The dimensions exhibited by gold nanoparticles are also on the 
same scale as the cellular species of interest.  Gold nanoparticles can be easily observed 
20 
under electron microscope due to their high electron density and specific manufactured 
shape, as seen in Figure 3.1.  It is these unique properties that have garnered attention for 
gold nanoparticles for use in biosensors, diagnostic assays, imaging, and targeted drug 
delivery.  For the purposes of this study, the latter two applications will be discussed 
further in the next section. 
 
 
3.2 Gold Nanoparticles for Use in Imaging 
 As discussed previously, gold nanoparticles have a high electron density that 
makes them easily visible using electron microscopy as well as X-ray analysis
23
.  This 
can aid in the detection of diseases, as the nanoparticles can first be conjugated with 
antibodies and then imaged for diagnosis
24
.  Nanoparticles can also be loaded with 
various contrast agents like gadolinium to increase sensitivity in imaging modalities such 
as magnetic resonance imaging and computed tomography, just to name a few.  And due 
to the small size of the gold nanoparticles, they are not removed from the body quickly 
and allows for longer imaging time
25
.  Gold nanoparticles also exhibit the property of 
localized surface plasmon resonance (LSPR), which is described as collective oscillation 
Figure 3.1: SEM Image of Spherical  
Gold Nanoparticles of 20 nm  
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of conductive electron under light excitation.  This property allows gold nanoparticles to 
also be observed using dark field microscopy of biological samples
26
. 
 
3.3 Gold Nanoparticles for Use in Targeted Drug Delivery 
 Drugs can have many routes of administration depending on the application, and 
ultimately the drug should reach its intended target either on its own or with the help of 
cellular transport.  However, orally and intravenously administered drugs may not reach 
their target or could target other parts of the body that can lead to unintended negative 
side effects.  This has led to the development of smart drug delivery which specifically 
targets the diseased tissue and is more effective than traditional means of drug delivery.  
The approximate equation for the time it takes for solute species to diffuse into a tissue 
can be given as   
  
  
  where x is the mean distance traveled and D is the diffusion 
coefficient of the solute of interest.  It can be seen that diffusion time increases with the 
square of the distance to be traveled, and thus in the case of articular cartilage of 2-4 mm, 
gold nanoparticles would take far too long to permeate the tissue by passive diffusion.  
For this purpose, gold nanoparticles could be used to deliver drugs more precisely and 
rapidly at in articular cartilage applications due to the convective transport that 
physiological motion causes in the joint. 
 As discussed previously, gold nanoparticles can be conjugated with antibodies, 
proteins, growth factors, or other targeting moieties via surface modification.  This allows 
for the gold nanoparticles to selectively target the cells or subcellular components of 
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interest.  The surface modification is achieved by adsorption of the ligand to the surface 
of the nanoparticle
27
.  For example in the treatment of cancer, gold nanoparticles can be 
conjugated with antibodies with specificity for epithelial growth factor
28
, which is a 
defining characteristic of cancerous tumors.  Additionally, once the gold nanoparticles 
have reached the intended target, infrared light can be used to melt the particles to release 
the drug payload in a controlled and sustained manner
29
.  This occurs due to gold’s 
unique property of converting absorbed light into heat via localized photoactivation.  
 In the field of cartilage tissue engineering, there is not a large body of research on 
the topic of gold nanoparticles for use in treating articular cartilage damage.  However, 
Park and his colleagues have shown that nanoparticles could be loaded with transforming 
growth factor β1 (TGF- β1) to slowly release the growth factor to chondrocytes resulting 
in increased levels of collagen and aggrecan
30
.  The nanoparticle constructs were also 
implanted into nude mice and induced chondrocytes to produce an abundant amount 
extracellular matrix rich in proteoglycans
30
.  Thus, the nanoparticles could be 
successfully used to deliver growth factors to diseased articular cartilage to attempt to 
repair the damage.  This has far-reaching implications as gold nanoparticles could be an 
effective means of delivering drugs, growth factors, or genes to defects in the articular 
cartilage
31
, but further investigation must be performed to determine the biological 
mechanisms of gold nanoparticle permeation into the tissue. 
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CHAPTER 4: DESIGN OF A LOW-COST CUSTOMIZABLE DYNAMIC 
COMPRESSION APPARATUS 
 
In order to characterize the biomechanics of articular cartilage and the potential 
for using gold nanoparticles to permeate into the tissue, the physiological environment of 
the tissue must be mimicked.  The following chapter gives an overview of the 
requirements necessary in designing a cartilage bioreactor to replicate the loading found 
in the joints as well as the various devices found most commonly in the literature.  The 
chapter discusses the apparatus that was constructed and its effectiveness in articular 
cartilage applications. 
 
4.1 Background 
 The biochemical composition of articular cartilage in joints and resulting 
biomechanical fluid pressurization in response to loading give it unique properties that 
allow it to disperse mechanical loads effectively.  Thus, it is apparent that mechanical 
loading must play a major role in the normal functionality and health of cartilage.  
Specifically, the proteoglycan content of cartilage provides the tissue with the innate 
ability to resist the everyday compressive forces experienced in the joints.  It has been 
shown that static compression of articular cartilage results in a decrease in proteoglycan 
content, while dynamic compression of the cartilage increases proteoglycan content
32,33
.  
Additionally, solutes diffuse into the articular cartilage from the surrounding synovial 
fluid by passive diffusion as well as convective transport induced by dynamic 
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compression loading of the joint
34
.  Thus in an attempt to characterize the permeation of 
any substance into the tissue, the physiological conditions of the joint must be replicated 
in a bioreactor with a tightly controlled environment
35
. 
 A bioreactor is an engineered device that functions to mimic the body’s own 
biological, chemical, and mechanical conditions for the tissue or cells that are to be 
housed within the chamber.  Under optimum conditions, the tissue or cells will have the 
same structure, properties, and integration that can be observed in vivo
35
.  For the 
purposes of this study, a bioreactor specifically for articular cartilage must be constructed 
and manufactured to control both physiological mechanical and biological stimuli for 
tissue explants.  There are several general requirements to keep in mind when designing a 
bioreactor device, and they are as follows: simplicity, material selection, and sensor 
incorporation
35
.   
 Simplicity should be a defining characteristic in the final design of the 
manufactured device, so as to make it as smooth as possible in running the necessary 
experiments.  The simplicity is important both in making the bioreactor effective in 
reducing exposure of the tissue to non-ideal conditions as well as in ease of use for the 
operator. There should be as few moving parts and machined recesses as possible to 
avoid any possible sources of contamination to the chamber environment.  The device 
must also a short disassembly and reassembly time to ensure efficiency and reduction in 
the time outside of the incubator for the tissue or cells.  In addition to making the device 
more effective in maintaining optimal conditions, the device should incorporate elements 
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that make it more user-friendly and allow it to be easily controlled.  The device should 
also be as inexpensive as possible to make it more attainable. 
 Careful consideration should be given to the materials selection of the device to 
guarantee that the bioreactor can support the proper growth and function of the tissue or 
cells.  The materials that are to come in contact with any biological fluids or tissues must 
be bioinert to ensure that that it does not elicit an adverse response.  The device must be 
durable in withstanding the hot, humid (37°C, 95% relative humidity) environment of the 
incubator.  The materials in the device should also be easily sterilized with an autoclave 
to allow for quick processing and reuse.  Thus for the construction of the device, a 
biocompatible plastic should be selected for the loading chamber that is to house the 
cartilage tissue and a resilient metal should be selected for the rigid frame of the 
apparatus.  Additionally, the plastic that is chosen will also be transparent to allow the 
user to observe and monitor the experiment in progress.   
 When constructing the device especially for cartilage tissue applications, the 
mechanical stimuli to which the tissue is subjected must be controlled and monitored.  In 
this regard, certain pumps/motors and sensors must be implemented into the device 
construction, and they must be able to withstand the environment of the incubator.  They 
must be extremely accurate to apply and detect forces that are small enough for the 
physiological loading of the tissues or cells.  Thus for the construction of the device, 
various components must be used to apply small cyclical forces, detect the strain 
experienced by the cartilage tissue, and detect the loads placed upon the tissue. 
28 
 There are also specific biomechanical requirements that must be considered when 
designing a device that will mimic the physiological environment of articular cartilage, 
specifically with regard to loading conditions.  The device should be able to provide both 
static and dynamic compression loading
35
.  Dynamic compression is representative of the 
natural environment of cartilage in the joints because the physiological activities of daily 
living, such as running/walking, create a cyclical loading environment
36
.  It should be 
carefully controlled using a computer and data acquisition system; however, the device 
should also be able to do static compression for the purposes of applying a tare load, or 
pre-load, to mimic the physiological pressure of cartilage in a joint at rest
37
.  The 
apparatus should provide unconfined compression to the cartilage in the loading chamber 
using impermeable platens to act as the subchondral bone of natural cartilage
38
.  
Unconfined compression is defined as axial loading of the samples with free radial 
expansion, and it is more representative of the conditions observed in vivo
38,39
. 
 The device should be customized to operate in a physiological range of loading 
conditions, such as strains, frequencies, and waveforms.  Using various methodologies, 
such as explant studies and ultrasound imaging, researchers have found that strains in the 
range of 0-20% can be considered physiological
40-42
.  The device should also perform 
using displacement control as opposed to using load control, because this allows the 
samples to be tested from a true “zero”43.  Additionally, it has been found that the daily 
activities of normal running/walking result in loading frequencies in the joint of 
approximately 0.1-2 Hz
40
.  Ideally, the device would also have the ability to emulate 
loading conditions that are far above these ranges for further studies on impact loading
44
.  
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Sinusoidal waveforms would be the most useful for characterizing cartilage behavior
44
, 
but additional waveforms, such as saw-tooth and square, would provide the opportunity 
for further study.  These general and specific requirements must be incorporated into any 
mechanical design that is implemented. 
There are many different designs that can be used in constructing a dynamic 
compression loading device that produces axial motion, but they all must incorporate a 
linear actuator of some kind.  The most commonly found custom devices in the literature 
involve electro-mechanical and electro-magnetic actuators to provide the precision 
necessary for cartilage tissue engineering applications.  The analysis of these various 
designs, as well as a commercially available dynamic compression device, can be seen 
below in Table 4.1. 
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Table 4.1: Dynamic Compression Loading Devices Commonly Found in Literature  
 
Advantages Disadvantages 
Relevant 
Literature 
Electro-
Mechanical 
(Threaded 
Screw) Actuator 
Devices 
 Simple design 
 Low cost 
 Moderate precision 
 Prone to wear 
 Requires 
manufacturing of 
custom screw 
 Screw has many small 
recesses 
 Can’t do high 
frequencies with 
stepper motor 
 Requires high 
precision feedback 
monitoring 
 Limited to sinusoidal 
waveforms of loading 
Frank et al.;  
Hunter et al.;  
Lee et al.;  
Parkkinen et al.
45-48
 
Electro-
Mechanical 
(Eccentric Cam) 
Actuator Devices 
 Simple design 
 Small, compact 
 Few small recesses 
 Low cost 
 Moderate precision 
 Prone to wear 
 Requires 
manufacturing of 
custom cam 
 Limited to sinusoidal 
waveforms of loading 
Cassino et al.; 
Mauck et al.
49,50
 
Electro-
Magnetic 
Actuator Devices 
 High precision 
 Smooth with high 
regularity 
 Able to produce many 
waveforms of loading 
 Complex design 
 Requires high 
precision position 
feedback monitoring 
 High cost 
Lujan et al.; 
Krishnan et al.;  
Park et al.
40,51,52
 
Commercially 
Available 
Devices 
 No manufacturing 
required 
 Reliable 
 Customer support  
 No customization 
 High cost 
Flexcell
® 
Compression 
Systems 
Bose ElectroForce
®
 
System 
 
 One of the most popular and easiest implemented designs is that of the electro-
mechanical actuator device, specifically with regard to a threaded screw construction.  It 
utilizes the principle that with each turn of the actuator’s nut, the shaft of the screw 
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moves vertically to produce linear motion from rotary motion.  The relevant literature 
accomplished devices based on this principle using a lead screw
45,46
 or a ball screw (lead 
screw with ball bearings) that were rotated with a stepper motor.  A stepper motor is an 
electric motor that can be controlled digitally for precise positioning in axial loading 
applications requiring very small magnitudes.  This design is simple, carries a relatively 
low cost compared to others, and offers a moderate degree of precision.   However to 
achieve the precision necessary for cartilage tissue compression, the screw should be 
custom-manufactured, and it also requires high precision monitoring components to get 
feedback on the screws location during loading.  This will add significantly to the cost if 
precise experiments are to be conducted.  Additionally, this design is limited to lower 
frequencies and sinusoidal waveforms, which may be of interest in future studies. 
Another type of device found in the literature involved the use of an electro-
mechanical actuator known as an eccentric cam.  An eccentric cam is a disc that has a 
rotational point that is geometrically off-centered.  It is attached to a rotating shaft 
powered a motor (a stepper motor in this case), and asymmetrical motion is produced as 
the cam itself turns.  A piece known as a follower is placed in contact with the eccentric 
cam, so that with each rotation of the cam, linear motion is produced.  This design is also 
simple, carries a relatively low cost compared to others, and offers a moderate degree of 
precision.  It is also small and compact without the many recesses found in the threaded 
screw design that are possible sources of microbial contamination.  The only 
disadvantages to this type of device are its moving parts, which are a source of wear, and 
the custom manufacturing required for the eccentric cam. 
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 Some of the more complex dynamic compression loading devices involved the 
implementation of a electro-magnetic actuator, such as a voice-coil
40,52
.  A voice coil uses 
a current passed through it to produce a magnetic field in which the coil itself moves 
through, resulting in linear motion.  It is typically seen in audio speakers, but can be 
modified for use in precise motion control applications.  This design has a higher degree 
of precision, due to the need for extremely accurate monitoring components for position 
feedback, and it offers smoother movement with a high degree of regularity.  However in 
light of these facts, it is a much more complex design that carries with it a high cost of 
production. 
 There are also commercially available compression devices on the market, such as 
the Flexcell
® 
FX-5000™ Compression and Bose ElectroForce® Sytems.  It utilizes a 
pneumatic actuator to produce axial dynamic compression on tissue samples or cells.  
The advantages to using this piece of equipment, or others like it, are its reliability and 
customer support that come with it as well as the fact that no custom manufacturing is 
required to perform the compression experiments of interest.  However, this device is 
extremely expensive and offers no customization if the user desires to expand the range 
of experimental conditions. 
 According to the requirements and literature discussed previously, a design 
utilizing the eccentric cam principle of linear motion should be selected due to its low 
cost and ease of manufacturing.  It has the simplest design with a degree of precision 
necessary to replicate the mechanical loading environment of cartilage tissue in the joint.  
However, the design should leave room for scale-up opportunities in the future to allow 
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for the expansion of its capabilities.  The preliminary designs can be seen below in Figure 
4.1, and involve the use of a stepper motor, linear variable displacement transducer 
(LVDT), and load cell.  These components and the construction of the device are 
discussed further in the next section. 
 
 
 
 
 
 
 
 
4.2 Materials and Methods 
 The support structure of the device was constructed using two 316L stainless-steel 
plates screwed together into an L-shape rigid frame.  The bottom plate measured 12.70 
cm by 15.24 cm with a thickness of 1.27 cm.  The vertical plate measured 22.86 cm by 
15.2 cm with a thickness of 1.27.  A bipolar NEMA23 stepper motor (STP-MTR-23055, 
Automation Direct, Cumming, GA) was mounted to the back of the vertical plate and was 
attached to an industrial positive drive belt (90XL025, Good Year, Akron, OH).  The belt 
was then attached to a 316L stainless-steel cam shaft with a length of 8.89 cm that went 
Figure 4.1: Sketches of Customized Dynamic Compression Loading Device 
Paper and pencil sketch (left); SolidWorks 3D sketch (right) 
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through the vertical plate via a hole that was machined into the plate.  A standard 
stainless-steel ball bearing cage with an outer diameter of 2.86 cm was used in the hole to 
reduce the rotational friction of the cam shaft and ensure smooth axial loading of the 
device after assembly.  Additionally, spacers (4.60 cm by 3.02 cm by 1.27 cm) and a 
bearing holder (7.62 cm by 4.60 cm by 1.27 cm) of 316L stainless-steel were mounted to 
the front of the vertical plate to allow for the placement of another 2.86 diameter 
stainless-steel ball bearing cage on the front end of the cam shaft.  An eccentric cam was 
placed on the end of the cam shaft to allow for cyclical axial loading of the device.  The 
eccentric cam was custom manufactured out of 316L stainless-steel using two circular 
plates with a diameter of 3.81 cm.  The first plate served as the cam holder (thickness of 
1.27 cm), and it went onto the cam shaft through a hole in the back of the plate.  The 
other plate was the cam itself (thickness of 0.95 cm), and it was attached to the cam 
holder via two front mounted screws.  The cam has two vertical teeth that extended the 
length of the plate to allow the cam to slide up and down on the cam holder.  This 
allowed the operator of the device to manually adjust the range of axial motion.   
Just below the eccentric cam was the 316L stainless-steel slide rail mounting 
block, which was fixed to the front of the vertical plate, and the 316L stainless-steel 
plunger/bearing holder.  A small slide rail system was attached to the mounting block and 
the plunger/bearing holder was screwed into the slide rail to allow for vertical motion.  A 
316L stainless-steel spring was placed on the underside of the plunger/bearing holder to 
allow it to return to its position at end of each rotation.  Following the eccentric cam was 
another stainless-steel bearing cage with an outer diameter of 2.23 cm that was screwed 
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into the plunger/bearing holder.  This bearing and the plunger/bearing holder served as 
the cam follower to allow for cyclical vertical motion.  A miniature linear variable 
differential transformer (LD400-1, Omega, Stamford, CT), or LVDT, was attached to 
both the eccentric cam bearing holder and the plunger/bearing holder.  It was used as a 
transducer to measure linear displacement and to help provide a means of monitoring 
strains on the samples.  A 316L stainless-steel plunger shaft with a diameter of 1.27 cm 
was housed inside a hole on the underside of the plunger/bearing holder and it was held 
in place using two thumb screws.  These screws were placed on the front and the side of 
the plunger/bearing holder to allow the user to manually adjust the amount of pre-load on 
the samples in the loading chamber. 
 The loading chamber for tissue samples was constructed entirely using 
polycarbonate and consisted of an indenter or platen, 12-well tray, and petri dish holder.  
The indenter was a flat impermeable plate with a 7.62 cm diameter and it had a threaded 
hole at its center so that the threaded end of the plunger could be screwed into the 
indenter.  A standard petri dish lid with a bored hole in the center was first placed onto 
the indenter before securing the plunger into it.  This indenter served as the platen that 
would actually contact the samples and distribute the load evenly across each one.  The 
petri dish holder was machined with a 10.16 cm outer diameter and an inner indention of 
8.73 cm diameter to hold a standard petri dish.  A standard shallow petri dish was used as 
a loading chamber in the apparatus, and it was placed on top of the petri dish holder.  A 
12-well tray with a diameter of 8.26 cm was manufactured to be positioned within the 
petri dish for sample placement.  A miniature through-hole load cell (LC8100-200-10, 
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Omegadyne, Sunbury, OH) was attached to the bottom of the petri dish holder and laid 
flat against the surface of the base plate to serve as a transducer to measure force on the 
samples. 
 The electronics that act as signal conditioners and controllers for the stepper 
motor (STP-DRV-4035, Automation Direct, Cumming, GA), LVDT (INA118P, Burr 
Brown, Tucson, AZ), and load cell (DRF-LC-24VDC-20MV-0/10, Omega, Stamford, 
CT) were mounted onto an aluminum sheet with the 24V power supply (S8VM-
10024AD, Omron, Schaumburg, IL).  The assembled dynamic compression apparatus 
was controlled and monitored using a custom-built graphical program in LabVIEW 2011 
that allows for observation of various outputs such as load and strain.  A data acquisition 
or DAQ card (NI USB-6009, National Instruments, Austin, TX) was used to convert the 
analog signals of the stepper motor, LVDT, and load cell into digital values that could be 
processed by the computer.  Refer to Appendix A for a more detailed look at the device 
drawings and LabVIEW code. 
 To validate that the device was inexpensive, a cost analysis of the components 
used to produce the custom-made dynamic compression loading apparatus was 
conducted.  Additionally as a validation experiment of the working parameters of the 
device, 12 cork samples of 1.5 mm thickness were produced using a 5 mm biopsy punch 
and placed into the loading chamber as various loading conditions of 0-20% strain at 1 
Hz frequency were tested.   
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4.3 Results 
 The customized pieces of the dynamic compression loading apparatus were 
manufactured at a local machine shop using 316L stainless-steel for the rigid structural 
components of the device and polycarbonate for the loading chamber components.  The 
pieces were assembled along with the motor and sensory hardware, seen in Figure 4.2 
below. 
 
 
 
 
 
 
 
 
 
2  
 
 
 The eccentric cam and cam follower plunger/bearing that act as the linear actuator 
can be seen more readily in the expanded view of Figure 4.3.  The electronics that 
provide the signal inputs and outputs to allow communication between the computer and 
the device are clearly labeled in Figure 4.4. 
Eccentric Cam 
LVDT 
Loading Chamber 
Load Cell 
Stepper Motor 
Gear Belt and Assembly 
Figure 4.2: Views of the Assembled Dynamic Compression Device 
Front view (left); rear view (right) 
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Petri Dish and Indenter 
Spring 
Figure 4.3: Expanded View of Linear 
Actuator System 
Figure 4.4: View of the Electronics for Device Communication 
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   Table 4.2: Physical Specifications of the Dynamic Compression Device 
 Specifications 
Frequency 0.1-10 Hz 
Strain ~0-40% 
Waveforms possible Sinusoidal only 
Materials 
316L stainless-steel (frame) 
Polycarbonate (loading chamber) 
Dimensions 
26.26 cm (height) 
15.24 cm (width) 
12.7 cm (depth) 
  
Table 4.3: Cost Analysis of Assembled Dynamic Compression Loading Apparatus 
Device Component Component Product 
Number 
Price 
Bipolar stepper motor STP-MTR-23055 $35.50 
Stainless-steel ball bearing cages (3) Standard $42.14 
Gear belt and assembly 90XL025 and standard $105.41 
Linear Slide Rail Standard $154.95 
LVDT LD400-1 $387.37 
Load cell LC8100-200-10 $497.37 
Stepper motor driver STP-DRV-4035 $166.25 
Load cell signal conditioner DRF-LC-24VDC-20MV-0/10 $217.37 
Multi-function DAQ card NI USB-6009 $251.10 
24 V power supply S8VM-10024AD $161.35 
Various electronics  Assorted components ~$100.00 
Mounting hardware Standard ~$20.00 
Aluminum mounting plate Standard ~$64.00 
Bulk material 316L Stainless-Steel ~$200.00 
Bulk material Polycarbonate ~$100.00 
 Total ~$2500.00 
 
 Table 4.2 gives the physical specifications of the assembled device in both its 
performance and measurements to indicate whether specific design targets discussed 
previously were met.  The dynamic compression apparatus is displacement controlled and 
as such there are no specifications given for the load.  Table 4.3 is a cost analysis of the 
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completed device to indicate the expenses incurred as well as to analyze its cost-
effectiveness.   
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Figure 4.5: Load Measurements of Cork Samples 
Figure 4.6: Strain Measurements of Cork Samples 
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 Cork samples were used for validation of the dynamic compression apparatus and 
the graphs for the resulting load per sample and strain outputs at various time points can 
be seen in Figures 4.5 and 4.6, respectively.  The purpose of these graphs is to show the 
reliability and consistency of the device during the course of an experiment.  The loading 
per sample and strain at each of the various time points is given in Table 4.4 as an 
average with the standard deviation.  Using a one-way ANOVA test with a Tukey 
method of multiple comparisons, the samples at the 1 minute time point showed loading 
that was statistically different (p<0.05) from the other time points.  The range of the 
loading per sample values at each of the time points recorded were approximately 0.14 to 
1.22 N (1 minute), 0.10 to 1.13 N (1 hour), and 0.12 to 1.07 N (2 hours).  The range of 
the strain values at each of the time points recorded were approximately -4.20 to 18.97% 
(1 minute), -2.65 to 15.58% (1 hour), and -2.59 to 16.65% (2 hours).   
 
Table 4.4: Average Load and Strain Values of Cork Samples 
 1 Minute 1 Hour 2 Hours 
Load per sample [N] 0.64±0.31* 0.49±0.27 0.50±0.28 
Strain [%] 6.46±6.08 6.51±5.75 6.40±5.75 
*Statistically significant difference (p<0.05) compared to other time points 
 
Lastly, the total stress over all 12 samples was calculated, and the strain-stress 
behavior of the cork samples was graphed for a single representative cycle at the 1 hour 
time point (Figure 4.7).  The peak stress appears to be approximately 0.55 MPa and 
occurs at approximately 13% strain. 
42 
0
0.1
0.2
0.3
0.4
0.5
0.6
0 2 4 6 8 10 12 14 16
To
ta
l S
tr
e
ss
 [
M
P
a]
 
Strain [%] 
Strain-Stress Behavior of Cork Samples In 
Dynamic Compression  
 
Figure 4.7: Strain-Stress Behavior of Cork Samples  
 
4.4 Discussion 
 The assembled device proved to be capable of effectively providing dynamic 
axial loading on samples in the polycarbonate chamber.  The electronics allowed for the 
frequency of loading to be digitally controlled with the aid of a computer, and it also 
provided outputs of the loading per sample as well as the strain.  The desired 
displacement had to be set manually before experimentation, and the procedure for doing 
so can be found at the back of Appendix A.  Physically, the device was able to produce 
physiological frequencies in the range of 0.1-2 Hz and even as high as 10 Hz, which 
would be useful in doing high impact loading in future studies.  The apparatus was able 
to produce physiological strains in the range of 0-20% and even as high as 40%, which 
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will also be useful in doing high impact loading in future studies.  Unfortunately the 
device, due to its electro-mechanical linear actuator, is only able to produce sinusoidal 
waveforms.  This is adequate for the current study of articular cartilage biomechanics, but 
other waveforms may be required in future studies.  The device was constructed of 316L 
stainless-steel, which resists the harsh conditions of the incubator, and polycarbonate, 
which acts as a biocompatible loading chamber for biological samples.  The assembled 
product also has dimensions that allow for it to fit easily into a standard incubator.  
Lastly, the device was shown to have a relatively low cost in comparison to other types 
found in the literature. 
 The validation tests with the cork samples were able to prove that the device 
performs reliably with consistent outputs of load and strain data over the course of an 
experimental trial.  The average loading per sample for the first time point was found to 
have a statistically significant difference (p<0.05) compared to the other time points, and 
this could be due to the device needing an equilibration period that is longer than one 
minute.  The strain values that were observed in this validation test indicate that the range 
is relatively close to the 0-20% strain that was set, but negative strains were observed in 
the range.  This does not mean that lift-off of the samples is occurring; instead, it 
indicates that the device was improperly zeroed before experimentation began.  This is 
important for obtaining accurate data and must be considered more closely for the 
remainder of this study.  The strain-stress behavior of the cork samples was graphed for a 
single representative cycle at the 1 hour time point because it was at this point that it 
seemed the device had reached an appropriate equilibrium to obtain accurate 
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measurements.  The profile and plateau stress that was observed in the graph matches 
what is found in the literature for the strain-stress behavior of agglomerate cork 
behavior
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. 
4.5 Conclusion 
 The custom-designed dynamic compression apparatus that has been constructed 
and assembled fulfills the desired requirements to be simple, low-cost, durable, and 
capable of providing axial loading within established parameters.  It has proven to be an 
accurate and reliable device that can effectively be used to provide physiological loading 
conditions in the study of articular cartilage tissue biomechanics.  The device will be used 
further in the next chapter to provide dynamic compression to cartilage tissue explants to 
observe gold nanoparticle permeation.  In the future, the device could incorporate 
hydrostatic flow into the loading chamber to ensure a constant concentration of the 
nanoparticles of interest in media.  Additionally, the device could incorporate a ball and 
socket pivot joint at the intersection of the indenter and plunger.  This would allow for 
easier removal of the loading chamber as well as for making sure that the indenter can 
contact all of the samples effectively.  To integrate shear forces into the design and thus 
make it even more physiological, the loading chamber could be made to rotate using the 
stepper motor.   
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CHAPTER 5: GOLD NANOPARTICLE PERMEATION IN RESPONSE TO 
DYNAMIC COMPRESSION OF ARTICULAR CARTILAGE 
 
In order to determine the potential for using gold nanoparticles as a drug delivery 
system in articular cartilage repair, the permeability as well as the convective transport of 
the nanoparticles in physiologically loaded tissue must be observed.  The following 
chapter details the experiments that were conducted to characterize the permeation of 
gold nanoparticles into articular cartilage under various loading conditions.   
 
5.1 Background 
 The primary function of cartilage found in the joints is to provide a smooth, 
articulating surface between bones as well as to act as a shock absorber in distributing 
loads.  The tissue is flexible and resilient with a low coefficient of friction to perform 
these tasks effectively.  The main components that make up the dry-weight of articular 
cartilage are collagen fibers and large macromolecules called proteoglycans.  The 
collagen fibers function to resist tensile forces experienced by the joint, while the 
proteoglycans function to resist compressive forces experienced by the joint.  In 
particular, the mechanical loading that is of utmost importance to the study of the 
biomechanics of physiological articular cartilage is that of unconfined axial 
compression
39
.  The reason that cartilage is so effective in dispersing compressive loads 
is due to the unique physical properties that are offered by the chemistry of the 
proteoglycan in the extracellular matrix.  The proteoglycans have glycosaminoglycan 
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(GAG) chains made up of chondroitin sulfate, keratin sulfate, and hyaluronan.  These 
chains have an overall net negative charge that lends a high degree of hydrophilicity to 
the proteoglycan macromolecules.  Thus, articular cartilage contains consists of 60-80% 
water that is pressurized during compression and supports the majority of the load. 
 Changes to the biochemical composition of the extracellular matrix due to high 
impact injury or aging can cause a reduction in the water content of cartilage.  This 
results in cartilage pathology as there is decreased fluid pressurization and higher loading 
on the tissue itself.  Over time the tissue will experience degradation, and this is readily 
seen in osteoarthritis with widespread structural damage of grades II and III.  It is the 
most common joint disorder affecting over half of the adult population, and it is on the 
rise.  Unfortunately articular cartilage has an extremely limited capacity for self-renewal.  
This inability to repair is primarily due to the avascular nature of cartilage, meaning all of 
the nutrients must come from the surrounding synovial fluid via diffusion.    Articular 
cartilage exhibits permeability properties that favor the passive diffusion of small 
molecules, and it is mediated by the physiological motion in the joint.  This property 
could possibly be used advantageously in drug delivery systems of small molecules. 
 Nanotechnology is a field that is garnering a lot of attention lately for its potential 
for use in a multitude of biomedical applications.  Specifically, gold nanoparticles have 
many properties that make them ideal candidates in smart drug delivery systems.  They 
can be manufactured to many different sizes and shapes depending on the application.  
Gold nanoparticles are biocompatible and can undergo surface modification to target 
specific biological sites of interest, thereby making them more precise in delivery 
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compared to traditional means of drug administration.  They are on the same scale as the 
cellular species of interest, and due to their small size, the nanoparticles are not quickly 
removed from the body allowing prolonged drug delivery times.  They can also be easily 
characterized using electron microscopy due their high electron density.  Various drugs, 
growth factors, or genes could be conjugated on gold nanoparticles to make them 
effective in treating articular cartilage damage.  This is an area of research with great 
potential, but the loading conditions that optimize permeation of gold nanoparticles into 
articular cartilage must first be studied. 
5.2 Materials and Methods 
 Articular cartilage explants were harvested from the tibio-femoral joints of freshly 
slaughtered porcine juveniles (less than 1-year-old) obtained from a local abattoir.  The 
joint was exposed, and the articular surface of the femoral condyle was sliced in 
horizontal sections.  A 5 mm biopsy punch was then used on the flat slices to obtain 
cartilage plugs with an approximate thickness of 1.5 mm.  If the samples were measured 
to be too thick, the surface of the underlying subchondral bone could be removed with the 
aid of a scalpel to achieve the correct thickness.  This is to ensure the samples are roughly 
the same thickness for uniform loading during experimentation
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.  After removal, the 
plugs were placed in sterile Hank’s Balanced Salt Solution (HBSS) that has been 
supplemented with 1% antibiotic/antimycotic solution (penicillin/streptomycin) and 1% 
antifungal solution (amphotericin B) to stabilize the tissue until loading.  
 Using sterile technique, up to 12 samples were then evenly placed with 10 mL of 
growth media into the petri dish loading chamber of the custom dynamic compression 
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loading apparatus discussed in the previous chapter, as shown in Figure 5.1.  For the 
experiments, a cartilage culture growth media was used, and it contained low-glucose 
Dulbecco’s Modified Essential Medium (DMEM) with 10 mM HEPES, 0.4 mM proline, 
0.02 mg/mL ascorbic acid, 10% fetal bovine serum (FBS), 1% nonessential amino acids, 
1% antibiotic/antimycotic solution (penicillin/streptomycin), and 1% antifungal solution 
(Amphotericin B).  For each experiment with gold nanoparticles, 2 mL of gold 
nanoparticle solution was also added to the 10 mL of growth media to yield a final gold 
nanoparticle concentration of ~1.08E11 particles/mL.  The gold nanoparticles used for 
this study had an average particle diameter of 20 nm and were suspended in 0.1 mM 
reactant-free PBS at a concentration of ~6.5E11 particles/mL (753610, Sigma Aldrich, 
St. Louis, MO). 
 
 
 
 
 
 
 
 The loading chamber with the samples was then placed into the dynamic 
compression device, and a static load was applied for one hour.  This allowed the 
Figure 5.1: Explant Placement in 
Loading Chamber 
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cartilage explants to equilibrate and ensured there was no creep behavior during 
experimentation.  After the allotted one hour, the strain and load were zeroed so that a 
nonzero pre-load could be established for the samples.  This offset load was set to make 
certain that the indenter maintained contact during the entire loading period with no lift-
off.  Then the loading parameters were set for each experiment (static compression at a 
strain of 7.5%, dynamic physiological compression of 0.1 Hz at a strain of 0-15%, and 
dynamic physiological compression of 1.0 Hz at a strain of 0-15%), and it was allowed to 
run for two hours.  Additionally, free-swelling cartilage explants were used as a control, 
and these samples were placed alongside the device in a standard petri dish with 10 mL 
of cartilage media and 2 mL of gold nanoparticles for the same time period.  
Measurements of the load and strain were taken after one hour of dynamic loading. 
 The following procedures were carried out in each experiment: 
 After loading, one explant and 1 mL of the cartilage media were set aside for 
biochemical analysis using a DMMB assay.  The sample that was set aside was digested 
in a solution containing 10 mg of Pronase E (P8811, Sigma Aldrich, St. Louis, MO) and 
1 mL of distilled water.  It was incubated and shaken overnight at 56°C in an incubated 
orbital shaker until the cartilage was completely digested with no visible residue.  The 
digested cartilage explant and the media were then analyzed for proteoglycan content 
using a DMMB assay (see Appendix B for the protocol). 
The other samples were divided into two groups with half of the samples fixed in 
10% neutral buffered formalin for histological analysis, and the other half fixed in 2.75% 
gluteraldehyde (see Appendix D for details on formulation) for electron microscopy 
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analysis.  After at least two days of fixation, the formalin fixed samples were assigned a 
specimen number and processed using standard tissue processing procedure (using ethyl 
alcohol in increasing concentration, xylene as a clearing agent, paraffin as an infiltrating 
agent, and paraffin as an embedding agent).  The samples were then sectioned using an 
automatic microtome yielding 5μm thick sections that were placed on microscope slides.  
After drying overnight in an oven, the sections were stained using a hematoxylin & eosin 
(H&E) and a special safranin O green protocol (see Appendix C).  After staining the 
slides were coverslipped and imaged on a Nikon Labophot 2 standard light microscope 
with attached Sony HDR-HC9 high definition camcorder.  The histological analysis was 
done to observe if the various loading parameters caused any pathology in the tissue. 
 After at least two days of fixation, the gluteraldehyde fixed samples were 
assigned a specimen number and prepared for electron microscopy analysis using a series 
of increasing ethanol washes.  The SEM prepared samples were additionally immersed in 
HMDS, while the TEM samples were polymerized overnight in pure resin and sectioned 
using an ultramicrotome.  The SEM samples were then analyzed using a Hitachi SU6600 
Schottky Field Emission Analytical SEM microscope and a Hitachi HD2000 STEM 
microscope.  This was done to observe gold nanoparticles on the surface of the articular 
cartilage and to conduct an elemental analysis with energy-dispersive X-ray spectroscopy 
(EDX).  EDX focuses a high-energy beam at the sample and measures the energy of the 
X-rays that are emitted back as a result, which are unique depending upon the chemical 
composition of the location of interest on the sample.  The TEM samples were then 
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analyzed using a Hitachi H7600 TEM microscope.  This was done to observe gold 
nanoparticles that had penetrated into the articular cartilage. 
5.3 Results 
Articular cartilage samples were tested under various loading parameters to 
observe the effects of loading on gold nanoparticle permeation into the tissue, and the 
resulting load per sample and strain outputs for each set of conditions was graphed in 
Figures 5.2 and 5.3, respectively.  The purpose of these graphs is to show the specific 
loading conditions of each experiment.   
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Figure 5.2: Load Measurements of Articular Cartilage Explants 
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The loading per sample and strain in each experiment is given in Table 5.1 as an 
average with the standard deviation.  The range of the loading per sample values in each 
of the experiments were approximately 0.56 to 0.60 N (Static), 0.19 to 1.58 N (0.1 Hz), 
and 0.14 to 1.45 N (1.0 Hz).  The range of the strain values in each of the experiments 
were approximately 6.87 to 8.08% (Static), 0 to 16.89% (0.1 Hz), and 0 to 15.49% (1.0 
Hz).   
 
Table 5.1: Average Load and Strain Values of Articular Cartilage Explants 
 Static 0.1 Hz 1.0 Hz 
Load per sample [N] 0.58±0.01 0.78±0.45 0.68±0.41 
Strain [%] 7.55±0.20 9.02±5.27 7.42±4.96 
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Figure 5.3: Strain Measurements of Articular Cartilage Explants 
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 The DMMB assay was run on the digested cartilage and cartilage media for each 
experiment, and the values were compared to a standard curve (Appendix B) to obtain 
proteoglycan concentrations for each solution.  The resulting concentrations are shown in 
Figure 5.4 for the digested cartilage solution and Figure 5.5 for the cartilage media.  
Using a one-way ANOVA test with a Tukey method of multiple comparisons, no 
significant differences were found for the digested cartilage solutions.  However, a 
significant difference (p<0.05) was found for the cartilage media in which the explants 
had been loaded with static compression. 
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Figure 5.4: Proteoglycan Concentration in Digested Cartilage Solutions 
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 The histological images for each of the experiments after loading can be seen in 
the representative images of Figure 5.6.  All images were taken with a 10x objective 
(100x total magnification). In the H&E stain, the nuclei of the chondrocytes stain blue 
and the cytoplasm and other tissue elements stain various shades of pink.  In the Saf O 
Green stain, the nuclei stain purple/black, muccopolysaccharides stain orange red, and 
collagen fibers stain green. 
  
  
0.000
0.005
0.010
0.015
0.020
0.025
Static Loading 0.1 Hz Dynamic
Loading
1.0 Hz Dynamic
Loading
No Loading
C
o
n
ce
n
tr
at
io
n
 [
µ
g/
m
L]
 
DMMB Assay on Cartilage Media 
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Figure 5.6: Histological Analysis of Articular Cartilage after Loading 
Labeled on top and left side of the figure 
10x objective (100x total magnification); all scale bars are 100 μm 
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For each of the experiments after loading, representative images of the articular 
cartilage using scanning electron microscopy can be seen in Figure 5.7, and they were 
taken with the SU6600 SEM at 15k magnification and 60k magnification under variable 
pressure (VP) mode using a 20kV voltage.  Additionally using SEM, the image in Figure 
5.8 was taken with the HD2000 STEM at 450k magnification under VP mode using 
200kV.  This image shows a higher magnification (450k magnification) of a gold 
nanoparticle found in a 1.0 Hz dynamically compressed tissue sample, and it was 
measured to be approximately 23.24 nm in diameter.  Using the SU6600, EDX reports 
for the 0.1 Hz and 1.0 Hz dynamically compressed cartilage samples can be seen in the 
representative images of Figures 5.9 and 5.10, respectively.  The EDX results indicate a 
0.25±0.10 weight percent of gold in the 0.1 Hz dynamically compressed samples and a 
0.47±0.19 weight percent of gold in the 1.0 Hz dynamically compressed samples.  The 
EDX reports of the free-swelling control and the statically compressed samples were not 
included due to its inability to detect any gold for these samples.  All of the EDX results 
were compiled and summarized graphically, as shown in Figure 5.11.  It should be noted 
that only EDX reports showing gold with a detected weight percent at least two standard 
deviations above the sigma value were used.     
For the 0.1 Hz dynamically compressed samples and the 1.0 Hz dynamically 
compressed samples, representative images of the articular cartilage using transmission 
electron microscopy can be seen in Figures 5.13 and 5.14, respectively.  They were taken 
with the H7600 at 60k magnification under VP mode using a 120kV voltage.   
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Figure 5.7: SEM Analysis of Articular Cartilage after Loading  
Labeled on top and left side of the figure 
Scale bars are 3 μm for the images on the left and 500 nm for the images on the right 
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Figure 5.9: EDX Report for Samples in 0.1 Hz Dynamic Compression Loading 
Figure 5.8: Higher Magnification Image of Gold Nanoparticle 
23.24 nm 
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Figure 5.10: EDX Report for the Samples in 1.0 Hz Dynamic Compression Loading 
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Figure 5.11: EDX Detection of Gold in Samples 
* Statistically significant difference (p<0.05) compared other samples 
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Figure 5.12: TEM Analysis of 0.1 Hz Dynamic Compression Sample
Figure 5.13: TEM Analysis of 1.0 Hz Dynamic Compression Sample
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5.4 Discussion 
 The explant samples were tested under various loading conditions that were 
shown to be set accurately in the physiological range of articular cartilage using the 
custom dynamic compression loading apparatus discussed in the previous chapter.  For 
biochemical analysis after loading, a DMMB assay was conducted to measure the 
concentration of proteoglycans.  It was found that there was no difference between the 
amounts of proteoglycan in the digested explant for each experiment, and this could be 
due to short time frame under which the samples were tested.  In future studies, the 
explants could be tested for a longer time frame to observe the effects of various loading 
conditions on the stimulation of proteoglycans.  However, the concentrations that were 
found were outside of the range that the assay can detect using the standard curve found 
in Appendix B (0.01-0.05 μg/mL).  Adjustments to the protocol could be made in future 
experiments to obtain more reliable results on the proteoglycan concentration of the 
explants.  Additionally, it was found that there was a statistically significant difference 
between the amounts of proteoglycan in the cartilage media under static loading 
compared to the other samples.  This could be due to potential damage to the explants 
that is caused by the non-ideal conditions of static loading, as it has been shown in the 
literature to inhibit proteoglycan synthesis in articular cartilage
32,33
. 
 The histological analysis of the cartilage after loading indicates that no damage to 
the tissue can be readily observed.  The staining and morphology are characteristic of 
normal, healthy articular cartilage.  Thus, the loading conditions in each experiment 
appear to have no adverse effects on the samples. 
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 After histological analysis, each of the samples was imaged using scanning 
electron microscopy to observe the amount of gold nanoparticles on the surface of the 
tissue due to the various loading conditions.  In the SEM images that were obtained with 
the SU6600, no nanoparticles could be observed in the free swelling control or the 
statically compressed samples.  However, the samples in dynamic compression indicate 
the presence of nanoparticles that were roughly spherical in shape and had a high electron 
density due to their bright white appearance.  The nanoparticles were found to be much 
more prevalent in the samples after 1.0 Hz dynamic compression.  However, it could not 
be concluded solely from these images that the nanoparticles were the gold nanoparticles 
of interest.  Thus, a higher magnification image of a particle was required to determine 
size/shape and EDX was required to confirm the presence of gold. 
 The gold nanoparticles used for experimentation were 20 nm diameter spheres, 
and this is consistent with the findings of the higher magnification image indicating that 
the imaged particle was of a definite spherical shape with a diameter of 23.24 nm.  The 
EDX reports for the 0.1 Hz and 1.0 Hz dynamically compressed samples indicate the 
presence of gold in very small quantities, along with other elements known to be present 
in articular cartilage.  The EDX results that were graphically summarized indicate that 
there is a significantly significant difference (p<0.05) in the amount of gold detected in 
the samples.  It appears that the samples in 1.0 Hz dynamic compression loading have a 
higher presence of gold compared to the samples in 0.1 Hz dynamic compression 
loading.  The EDX results for the free-swelling control explants and the explants in static 
loading indicated that there is no gold to be found in these samples.   
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 Lastly, the samples in 0.1 Hz dynamic compression and 1.0 Hz dynamic 
compression were imaged using transmission electron microscopy to observe the amount 
of gold nanoparticle permeation into the tissue due to the various loading conditions.  In 
the TEM images that were obtained with the H7600, nanoparticles with a high electron 
density were observed due to the appearance of black spots in the sample that weren’t 
artifacts.  The nanoparticles were found to be much more prevalent in the samples after 
1.0 Hz dynamic compression.  It cannot be concluded from these images that the 
nanoparticles were the gold nanoparticles of interest, and EDX is ineffective at analyzing 
the chemical composition of a singular nanoparticle. 
5.5 Conclusion 
The dynamic compression device that was constructed in the previous chapter 
was effective at providing physiological loading to articular cartilage explants.  Under the 
various loading conditions that were tested, relatively no adverse effects were observed 
on the tissue.  From the SEM and EDX results, there seems to be sufficient evidence to 
conclude that the particles observed on the surface of the dynamically compressed 
samples is in fact the gold nanoparticles of interest.  From the TEM results, small 
nanoparticles that may potentially be gold were observed within the explants.  
Qualitatively, more gold nanoparticles were observed in the 1.0 dynamically compressed 
samples both on the surface and inside of the articular cartilage tissue as compared to the 
other samples.   
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CHAPTER 6: OVERALL CONCLUSIONS AND FUTURE WORK 
 
Research has been ongoing in the search for a cure for articular cartilage damage, 
especially in the case of osteoarthritis.  With an aging population and the prevalence of 
obesity, the need for a suitable treatment is growing.  Gold nanoparticles offer abundant 
potential as a smart drug delivery mechanism in bringing growth factors, drugs, or genes 
to diseased cartilage tissue in the joints.  However, not enough is known about the 
biomechanical aspect of gold nanoparticle permeation into this tissue. This research 
focused on determining the extent of gold nanoparticle permeation and the physiological 
loading conditions that optimize its convective transport. 
This work was able to find a means of providing loading conditions necessary in 
the study of articular cartilage through the design and construction of a custom dynamic 
compression apparatus.  It was also shown that under compressive loading of articular 
cartilage, gold nanoparticles were observed on the surface and potentially inside the 
tissue.  Gold nanoparticles were shown to permeate into the tissue with the addition of 
convective transport caused by higher frequency physiological motion.  This has clinical 
significance for determining an optimal loading regiment for delivering drugs in patients 
that may undergo gold nanoparticle treatment. Osteoarthritis has been shown to result in 
an increased permeability in the articular cartilage
55
, and therefore it is expected that 
there will be an increased amount of gold nanoparticle permeation into diseased tissue.   
However, more experiments should be conducted on osteoarthritic tissue to obtain more 
accurate data on the permeation of gold nanoparticles. 
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To continue this research, the amount of permeation of gold nanoparticles should 
be established quantitatively through the use of fluorescently-labeled gold nanoparticles 
that can be observed using standard fluorescent imaging as opposed to electron 
microscopy.  In this way, the amount of gold nanoparticle permeation in specific zones of 
the articular cartilage could be observed to draw more conclusions.  Additionally more 
research should be conducted on the permeation into the tissue over time to better 
characterize the diffusive phenomena that are occurring.   
 In the current work, gold nanoparticle permeation was observed, but using the 
dynamic compression loading apparatus, a multitude of unrelated experiments could be 
performed.  High impact loading studies or even studies on the loading of other tissues, 
such as dental pulp stem cells, could be conducted in the future. 
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APPENDIX A: ADDITIONAL DRAWINGS, COMPUTER CODE, AND 
PROCEDURES OF THE DYNAMIC COMPRESSION LOADING APPARATUS 
  
Figure A.1: Detailed CAD Drawing of the Vertical Plate 
Figure A.2: Detailed CAD Drawing of the Bottom Plate 
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Figure A.3: Detailed CAD Drawing of the Cam Assembly 
Figure A.4: Detailed CAD Drawing of the Plunger Assembly 
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Figure A.5: Detailed CAD Drawing of the Loading Chamber Assembly 
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Figure A.6: LabVIEW Block Diagram of Computer Control Code 
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Procedure for Operation of the Dynamic Compression Loading Apparatus 
1. Ensure all connections are secure (Power, USB, Load Cell, LVDT, Stepper 
Motor) and turn the device ON 
2. Open LabVIEW and run the program associated with the device 
a. Open LabVIEW 2011 
b. Open the existing Dynamic Loading System project  
c. Open the MainVI within the project 
3. Set sample thickness (0.5-2 mm) and number of samples (1-12 samples) 
4. After loading samples, insert the loading chamber  
a. Lift the plunger 
b. Insert loading chamber containing samples (ensuring sterile technique if 
necessary) 
c. Screw down plunger into the threaded hole of the indenter (may be helpful 
to lift the plunger slightly while screwing it down) and tighten the thumb 
screws (to ensure no movement during transfer to incubator) 
d. Place in incubator (running cords through back) and loosen plunger once 
placed 
5. Run the VI 
6. Rotate the cam to align the screw holes horizontally and click the Zero LVDT 
button 
7. Set the strain 
a. Rotate the cam to align the screw holes vertically 
b. Loosen the eccentric cam using a 7/64” Allen wrench 
c. Adjust the cam by pushing down or letting up with your finger until you 
achieved a strain that is half of the total desired strain (i.e. set 10% for 
total desired strain 20%) 
d. Tighten the cam using the Allen wrench 
e. Ensure that the strain is still at the correct value (sometimes it moves 
slightly when you tighten the cam so you may have to set it higher before 
tightening to compensate) 
8. Zero the LVDT 
a. Rotate the cam until the strain value is at zero (at the cam’s highest point) 
b. Click the Zero LVDT button 
9. Zero the Load Cell 
a. Slightly lift the platen off the samples (ensure sterility if necessary) 
b. Click the Zero Load Cell button 
c. Release, apply a little more load with your fingers, and tighten the platen 
(the non-zero value that is shown on the Force graph indicates the Pre-
load and this ensures that lift off does not occur during the loading cycle) 
10. Set motor speed 
a. Set the motor speed at the frequency you wish to run samples (0.1-10 Hz) 
b. Click the green button to begin dynamic compression 
11.  Use the export images button at various time points to record the data 
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APPENDIX B: BIOCHEMICAL ANALYSIS OF ARTICULAR CARTILAGE 
DMMB Assay of Cartilage Media/Digested Cartilage 
Written by: Alex Lindburg-MBEM Lab 
Materials 
1. Chondroitin sulfate (Sigma C4384) 
2. 1,9-dimethylmethylene blue reagent (Sigma 341088) [See Notes 1 & 2] 
3. Glycine 
4. NaCl 
5. HCl 
6. 96-well plates [with U-shaped bottoms] 
Directions 
1. 20 L aliquots of media in triplicate should be used for analysis. 
2. The sample with the GAG highest concentration should be tested so an 
appropriate dilution can be made [See Note 3]. 
3. A standard curve should be made for comparison of media to solutions of known 
chondroitin sulfate concentrations. The following dilutions should be made: 0.05, 
0.04, 0.03, 0.02, 0.01, 0.005, and 0 g/L. Make a working solution of 0.05 
g/L by adding 2.0 mg of CS powder to 40 mL of media. 
 
Working Solution (L)              Media (L)               Final Concentration (g/L) 
     100               0            0.05 
      80              20            0.04 
      60              40            0.03 
      40              60            0.02 
      20              80            0.01 
      10              90           0.005 
       0             100               0 
 
4. 180 L of DMMB is added to each well using a multi-channel pipet 
5. The absorbance at 530 nm is measured immediately with a microtiter plate reader. 
Notes 
1. The working solution is made by dissolving 16 mg of DMMB dye in 1 L of water 
containing 3.04 g glycine , 2.37 g NaCl, and 95 mL of 0.1 M HCl. 
2. The solution should be stored at room temperature in a brown bottle. The solution 
is stable for up to 2 months. 
3. The linear concentration of chondroitin sulfate in DMMB is limited to between 10 
and 50 g/mL (0.2 and 1.0 g in 20 L of solution). 
Reference 
Mort, JS and PJ Roughley. Measurement of glycosaminoglycan release from cartilage 
explants. (2007) Methods in Molecular Medicine. 135, 201-209. 
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Figure B.1: Standard Curve Used in DMMB Assay Results 
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APPENDIX C: HISTOLOGY PROTOCOLS 
Richard Allan
TM
 
Hematoxylin & Eosin Stain 
Written by: Linda Jenkins 
Fixation: Any 
Technique: Paraffin or frozen 
Solutions:  
Hematoxylin I 
Richard- Allan-----------------------Order # 7221 
Clarifier I 
Richard- Allan-----------------------Order # 7401 
Bluing Reagent 
Richard- Allan-----------------------Order # 7301 
Eosin-Y 
Richard- Allan-----------------------Order # 7111 
*Add “dash” of Phloxine B, C.I. #45410 to one pint of Eosin-Y and mix thoroughly 
Staining Procedure: 
1. Xylene    10 dips 
2. Xylene    5 minutes 
3. 100% EtOH   10 dips 
4. 100% EtOH   1 minute 
5. 95% EtOH   10 dips 
6. 95% EtOH   1 minute 
7. Tap water   30 seconds 
8. Distilled water  1 minute 
9. Hematoxylin   5 minutes 
10. Tap water   30 seconds 
11. Clarifier   30 seconds 
12. Bluing reagent  1 minute 
13. Tap water   1 minute 
14. 95% EtOH   10 quick dips 
15. Eosin    45 seconds 
16. 95% EtOH   10 quick dips 
17. 95% EtOH   10 quick dips 
18. 100% EtOH   10 dips 
19. 100% EtOH   1 minute 
20. 100% EtOH   3 minutes 
21. Xylene    10 dips 
22. Xylene    5 minutes 
Let slides remain in last container of xylene until a coverslip is applied 
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Special Staining Procedure 
Safranin O Green  
Written by: Linda Jenkins 
Fixation: 10% Neutral Buffered Formalin 
Technique: Paraffin 
Solutions: 
0.2% Fast Green 
0.1% Safranin O 
1% Glacial Acetic Acid 
Weigerts Hematoxylin A & B 
Staining Procedure: 
1. Xylene    10 dips 
2. Xylene    5 minutes 
3. 100% EtOH   10 dips 
4. 100% EtOH   1 minute 
5. 95% EtOH   10 dips 
6. 95% EtOH   1 minute 
7. Tap water   30 seconds 
8. Distilled water  1 minute 
9. Weigerts Hematoxylin 10 minutes 
10. Tap water   30 seconds 
11. Fast Green   5 minutes 
12. Acetic acid   3 dips 
13. Safranin O   6 minutes 
14. 95% EtOH   2 ½ minutes 
15. 95% EtOH   2 ½ minutes 
16. 100% EtOH   2 ½ minutes  
17. 100% EtOH   2 ½ minutes 
   *The final 100% alcohol must be absolutely clear to remove excess Safranin O 
18. Xylene    5 minutes 
19. Xylene    5 minutes 
Let slides remain in last container of xylene until a coverslip is applied 
  
81 
APPENDIX D: ELECTRON MICROSCOPY PREPARATION PROTOCOLS 
Gluteraldehyde Fixative and Rinsing Buffer Solution Preparation 
Written by: Clemson University Electron Microscope Facility Staff 
 
Preparation of Solution for 0.2 M Cacodylate Buffer 
1. 0.4 M sodium cacodylate  50 mL 
2. 0.2 M HCl    8 mL 
3. Distilled water to make  100 mL 
*The pH of the solution is adjusted to the required value with the HCl 
 
Preparation of Solution for 2.75% Gluteraldehyde: 
1. 0.2 M cacodylate buffer  50 mL 
2. 25% gluteraldehyde   10 mL 
3. Distilled water to make  100 mL 
*The pH of the solution is adjusted to the required value (typically 7.0) with HCl or 
NaOH and should be discarded if it drops below 3.5 
**Store in a dark bottle in the refrigerator.  It is stable for several weeks. 
 
Preparation of Solution for Rinsing Buffer 
1. Cacodylate    21.0 g 
2. Sucrose    73 g 
3. Distilled water   800 mL 
*The pH of the solution is adjusted to the required value (7.2-7.4) with HCl or NaOH 
**Bring to 1000 mL with distilled water 
  
82 
Procedure for TEM Preparation 
Written by: Clemson University Electron Microscope Facility Staff  
 
1. Rinse in rinsing buffer 
2. Dehydrate in EtOH 
a. 50% EtOH  15 minutes 
b. 70% EtOH  15 minutes 
c. 80% EtOH  15 minutes 
d. 95% EtOH  15 minutes 
e. 100% EtOH  30 minutes 
f. 100% EtOH  30 minutes 
g. 100% EtOH with embedding media (LR White) until samples sink to the 
bottom of the container 
h. Embedding media until samples sink to the bottom of the container (can 
put on a rocker plate to increase infiltration or refrigerate overnight) 
3. Embed into pure resin 
4. Polymerize at 60°C in an oven overnight 
5. Microtome using ultramicrotome and mount sections on TEM grids 
 
 
 
 
 
 
Procedure for SEM Preparation 
Written by: Clemson University Electron Microscope Facility Staff  
 
1. Dehydrate in EtOH 
a. 70% EtOH  10 minutes 
b. 85% EtOH  10 minutes 
c. 95% EtOH  10 minutes 
d. 100% EtOH  10 minutes 
2. Immerse tissues in HMDS for 15 minutes.   
3. Leave the HMDS in the containers and let it evaporate overnight at room 
temperature in a fume hood. 
4. Mount tissues on stainless-steel SEM stubs 
